Home/Filings/4/0001127602-18-013142
4//SEC Filing

Conti Kurt G 4

Accession 0001127602-18-013142

CIK 0001472091other

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 7:19 PM ET

Size

7.7 KB

Accession

0001127602-18-013142

Insider Transaction Report

Form 4
Period: 2018-03-23
Conti Kurt G
Director
Transactions
  • Other

    Common Stock

    2018-03-2358,4760 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By LLC)
    789,420
  • Common Stock

    324,541
Footnotes (5)
  • [F1]On March 23, 2018 three Trusts were dissolved and share ownership of 58,476 shares of common stock for which the Reporting Person had previously disclaimed beneficial ownership of transferred to the Reporting Person's three adult children who do not live in the same household as Reporting Person.
  • [F2]On March 23, 2018 the Austin Conti Trust was dissolved and share ownership of 29,238 shares of common stock for which the Reporting Person had previously disclaimed beneficial ownership of transferred to sole ownership of Austin Conti, the Reporting Person's adult child who does not live in the same household as Reporting Person.
  • [F3]On March 23, 2018 the Brooke Conti Trust was dissolved and share ownership of 14,619 shares of common stock for which the Reporting Person had previously disclaimed beneficial ownership of transferred to sole ownership of Brooke Conti, the Reporting Person's adult child who does not live in the same household as Reporting Person.
  • [F4]On March 23, 2018 the Hunter Conti Trust was dissolved and share ownership of 14,619 shares of common stock for which the Reporting Person had previously disclaimed beneficial ownership of transferred to sole ownership of Hunter Conti, the Reporting Person's adult child who does not live in the same household as Reporting Person.
  • [F5]The Reporting Person has sole voting and dispositive power over the shares held by Oakwood Capital, LLC and may be deemed to beneficially own these shares. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Issuer

Edge Therapeutics, Inc.

CIK 0001472091

Entity typeother

Related Parties

1
  • filerCIK 0001653204

Filing Metadata

Form type
4
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 7:19 PM ET
Size
7.7 KB